Australia has bio-medical hub potential
I met with the Chairman and CEO of Regeneus this week and was impressed by their commercialisation of stem cell therapies for humans and animals. I also liked their simple explanation of stem cells which is on the Regeneus web-site (click here to go to the web-site):
“Stem cells are the foundation cells for every organ, tissue and cell in the body. Stem cells are undifferentiated or “blank” cells that have not yet fully specialised. Stem cells are part of the tissue repair mechanism found in all mammalian tissue types. When a stem cell divides, each new cell has the potential either to remain a stem cell or differentiate into a specific cell type with a specialised function, such as a bone, cartilage or muscle cell, a red blood cell or a neuron. These characteristics distinguish stem cells from other cell types. They also have the capacity to secrete various compounds that can stimulate other cells to regenerate and repair.
There are many different types of stem cells. These include embryonic stem cells that exist only at the earliest stage of embryonic development and can form all cell types of the body. There are various types of “adult” or “tissue-specific” stem cells that exist in a number of different adult tissues like bone marrow and adipose (fat) tissue. It is known that different types of stem cells have different potential in regard to the cell types they can become. Regeneus only uses adult stem cells.”
Also on their web-site is the news that Japan is about to introduce a fast-track approval process for stem cell therapies (click here to read an article on this from nature.com).
Australian legislators should take note of this. Reducing bureaucracy related to bio-medical approval processes would help to facilitate the development of a world-class bio-medical hub in Australia.